We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FPE icon
426
First Trust Preferred Securities and Income ETF
FPE
$6.36B
$27.9M 0.04%
1,436,547
+320,594
+29% +$6.16M
WDAY icon
427
Workday
WDAY
$44.4B
$27.8M 0.04%
135,162
+16,883
+14% +$3.41M
MUB icon
428
iShares National Muni Bond ETF
MUB
$45.5B
$27.7M 0.04%
244,803
+1,213
+0.5% +$136K
ROIC
429
DELISTED
Retail Opportunity Investments Corp.
ROIC
$27.6M 0.04%
1,612,520
-52,582
-3% -$911K
XMLV icon
430
Invesco S&P MidCap Low Volatility ETF
XMLV
$748M
$27.6M 0.04%
538,368
-5,809
-1% -$295K
WRK
431
DELISTED
WestRock Company
WRK
$27.5M 0.04%
753,208
-9,127
-1% -$335K
CERN
432
DELISTED
Cerner Corp
CERN
$27.4M 0.04%
374,189
+39,613
+12% +$2.67M
MNST icon
433
Monster Beverage
MNST
$88.5B
$27.4M 0.04%
858,712
+71,976
+9% +$2.17M
HYMB icon
434
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.19B
$27.4M 0.04%
936,230
-125,584
-12% -$3.63M
XBI icon
435
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$27.4M 0.04%
311,833
-18,735
-6% -$1.6M
VNOM icon
436
Viper Energy
VNOM
$14.7B
$27.3M 0.04%
887,351
-31,859
-3% -$986K
PUK icon
437
Prudential
PUK
$35.2B
$27.2M 0.04%
639,933
-8,532
-1% -$355K
UN
438
DELISTED
Unilever NV New York Registry Shares
UN
$27.1M 0.04%
446,527
-6,196
-1% -$371K
VT icon
439
Vanguard Total World Stock ETF
VT
$79.8B
$27M 0.04%
359,591
-14,921
-4% -$1.11M
XLNX
440
DELISTED
Xilinx Inc
XLNX
$26.9M 0.04%
228,435
+23,147
+11% +$2.7M
MRSH
441
Marsh
MRSH
$91.5B
$26.9M 0.04%
269,820
+14,803
+6% +$1.42M
CHRW icon
442
C.H. Robinson
CHRW
$17.5B
$26.8M 0.04%
317,444
+110,534
+53% +$9.3M
DFS
443
DELISTED
Discover Financial Services
DFS
$26.7M 0.04%
344,325
-132,321
-28% -$10.2M
SPG icon
444
Simon Property Group
SPG
$72.3B
$26.7M 0.04%
166,823
+18,910
+13% +$3.26M
DG icon
445
Dollar General
DG
$27.9B
$26.5M 0.04%
195,754
+26,502
+16% +$3.35M
VLUE icon
446
iShares MSCI USA Value Factor ETF
VLUE
$9.44B
$26.4M 0.04%
325,336
+260,963
+405% +$20.9M
SU icon
447
Suncor Energy
SU
$70.3B
$26.4M 0.04%
846,763
+42,740
+5% +$1.37M
VFH icon
448
Vanguard Financials ETF
VFH
$13.6B
$26.2M 0.04%
379,337
+90,578
+31% +$6.15M
NEAR icon
449
iShares Short Maturity Bond ETF
NEAR
$4.85B
$26.1M 0.04%
518,166
+16,587
+3% +$833K
CELG
450
DELISTED
Celgene Corp
CELG
$26M 0.04%
281,727
-106,366
-27% -$10.1M

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.